Cheryl K Altice1, Matthew P Banegas2, Reginald D Tucker-Seeley3,4, K Robin Yabroff1. 1. Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA. 2. Center for Health Research, Kaiser Permanente, Portland, OR, USA. 3. Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, MA, USA. 4. Center for Community Based Research, Dana-Farber Cancer Institute, Boston, MA, USA.
Abstract
Background: With rising cancer care costs, including high-priced cancer drugs, financial hardship is increasingly documented among cancer survivors in the United States; research findings have not been synthesized. Methods: We conducted a systematic review of articles published between 1990 and 2015 describing the financial hardship experienced by cancer survivors using PubMed, Embase, Scopus, and CINAHL databases. We categorized measures of financial hardship into: material conditions (eg, out-of-pocket costs, productivity loss, medical debt, or bankruptcy), psychological responses (eg, distress or worry), and coping behaviors (eg, skipped medications). We abstracted findings and conducted a qualitative synthesis. Results: Among 676 studies identified, 45 met the inclusion criteria and were incorporated in the review. The majority of the studies (82%, n = 37) reported financial hardship as a material condition measure; others reported psychological (7%, n = 3) and behavioral measures (16%, n = 7). Financial hardship measures were heterogeneous within each broad category, and the prevalence of financial hardship varied by the measure used and population studied. Mean annual productivity loss ranged from $380 to $8236, 12% to 62% of survivors reported being in debt because of their treatment, 47% to 49% of survivors reported experiencing some form of financial distress, and 4% to 45% of survivors did not adhere to recommended prescription medication because of cost. Conclusions: Financial hardship is common among cancer survivors, although we found substantial heterogeneity in its prevalence. Our findings highlight the need for consistent use of definitions, terms, and measures to determine the best intervention targets and inform intervention development in order to prevent and minimize the impact of financial hardship experienced by cancer survivors. Published by Oxford University Press 2016. This work is written by US Government employees and is in the public domain in the US.
Background: With rising cancer care costs, including high-priced cancer drugs, financial hardship is increasingly documented among cancer survivors in the United States; research findings have not been synthesized. Methods: We conducted a systematic review of articles published between 1990 and 2015 describing the financial hardship experienced by cancer survivors using PubMed, Embase, Scopus, and CINAHL databases. We categorized measures of financial hardship into: material conditions (eg, out-of-pocket costs, productivity loss, medical debt, or bankruptcy), psychological responses (eg, distress or worry), and coping behaviors (eg, skipped medications). We abstracted findings and conducted a qualitative synthesis. Results: Among 676 studies identified, 45 met the inclusion criteria and were incorporated in the review. The majority of the studies (82%, n = 37) reported financial hardship as a material condition measure; others reported psychological (7%, n = 3) and behavioral measures (16%, n = 7). Financial hardship measures were heterogeneous within each broad category, and the prevalence of financial hardship varied by the measure used and population studied. Mean annual productivity loss ranged from $380 to $8236, 12% to 62% of survivors reported being in debt because of their treatment, 47% to 49% of survivors reported experiencing some form of financial distress, and 4% to 45% of survivors did not adhere to recommended prescription medication because of cost. Conclusions: Financial hardship is common among cancer survivors, although we found substantial heterogeneity in its prevalence. Our findings highlight the need for consistent use of definitions, terms, and measures to determine the best intervention targets and inform intervention development in order to prevent and minimize the impact of financial hardship experienced by cancer survivors. Published by Oxford University Press 2016. This work is written by US Government employees and is in the public domain in the US.
Authors: Kenneth M Langa; A Mark Fendrick; Michael E Chernew; Mohammed U Kabeto; Kerry L Paisley; James A Hayman Journal: Value Health Date: 2004 Mar-Apr Impact factor: 5.725
Authors: Stella Chang; Stacey R Long; Lucie Kutikova; Lee Bowman; Denise Finley; William H Crown; Charles L Bennett Journal: J Clin Oncol Date: 2004-09-01 Impact factor: 44.544
Authors: Ahsan M Arozullah; Elizabeth A Calhoun; Michael Wolf; Denise K Finley; Karen A Fitzner; Elizabeth A Heckinger; Nicolle S Gorby; Glen T Schumock; Charles L Bennett Journal: J Support Oncol Date: 2004 May-Jun
Authors: S Yousuf Zafar; Jeffrey M Peppercorn; Deborah Schrag; Donald H Taylor; Amy M Goetzinger; Xiaoyin Zhong; Amy P Abernethy Journal: Oncologist Date: 2013-02-26
Authors: Scott E Regenbogen; Christine M Veenstra; Sarah T Hawley; Mousumi Banerjee; Kevin C Ward; Ikuko Kato; Arden M Morris Journal: Cancer Date: 2014-05-29 Impact factor: 6.860
Authors: Matthew P Banegas; John F Dickerson; Nicole L Friedman; David Mosen; Althea X Ender; T Ruth Chang; Tracy A Runge; Mark C Hornbrook Journal: Perm J Date: 2019
Authors: Theresa A Hastert; Jaclyn M Kyko; Amanda R Reed; Felicity W K Harper; Jennifer L Beebe-Dimmer; Tara E Baird; Ann G Schwartz Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-05-06 Impact factor: 4.254
Authors: Jade C Newton; Claire E Johnson; Harry Hohnen; Max Bulsara; Angela Ives; Sandy McKiernan; Violet Platt; Ruth McConigley; Neli S Slavova-Azmanova; Christobel Saunders Journal: Support Care Cancer Date: 2018-04-27 Impact factor: 3.603
Authors: Joseph L Benci; Carolyn C Vachani; Christina Bach; Karen Arnold-Korzeniowski; Margaret K Hampshire; James M Metz; Christine E Hill-Kayser Journal: J Cancer Surviv Date: 2018-07-03 Impact factor: 4.442
Authors: Florence K L Tangka; Sujha Subramanian; Madeleine Jones; Patrick Edwards; Timothy Flanigan; Yevgeniya Kaganova; Kevin W Smith; Cheryll C Thomas; Nikki A Hawkins; Juan Rodriguez; Temeika Fairley; Gery P Guy Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-03 Impact factor: 4.254
Authors: Ashra Kolhatkar; Lucy Cheng; Steven G Morgan; Laurie J Goldsmith; Irfan A Dhalla; Anne M Holbrook; Michael R Law Journal: CMAJ Open Date: 2018-11-19